Oncology Institute revenue was $378.93M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $99.9M, up 1.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, TOI annual revenue was $324.2M, with 28.4% growth year-over-year.
TOI past revenue growth
How has TOI's revenue growth performed historically?
On Invalid Date, Oncology Institute (NASDAQ: TOI) reported Q3 2024 revenue of $99.90 million up 21.78% year over year. In the same quarter last year, Oncology Institute's revenue was $82.04 million.
What was Oncology Institute's revenue in 2023?
Oncology Institute's annual revenue for the twelve months ending Dec 31, 2023 was $324.24 million, a 28.42% increase year over year.
How much does Oncology Institute make in a day?
Based on Oncology Institute annual revenue for the past four years, TOI makes an average of $662,493.15 per day.
What was Oncology Institute's annual revenue growth in the past year?
As of Q1 2025, Oncology Institute's revenue has grown 22.29% year over year. This is 13.53 percentage points higher than the US Medical Care Facilities industry revenue growth rate of 8.75%. Oncology Institute's revenue in the past year totaled $378.93 million.
How much does Oncology Institute make in a year?
Oncology Institute's revenue by year for the past four years is:
Oncology Institute's revenue for the twelve months ending Dec 31, 2023 was $324.24 million, a 28.42% increase year over year.
Oncology Institute's annual revenue for Dec 31, 2022 was $252.48 million, a 24.37% increase from 2021.
Oncology Institute's annual revenue for 2021 was $203.00 million, a 8.26% increase from 2020.
Oncology Institute's annual revenue for 2020 was $187.52 million, a 20.66% increase from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.